Cargando…
Immunohistochemical Characterization of Connexin43 Expression in a Mouse Model of Diabetic Retinopathy and in Human Donor Retinas
Diabetic retinopathy (DR) develops due to hyperglycemia and inflammation-induced vascular disruptions in the retina with connexin43 expression patterns in the disease still debated. Here, the effects of hyperglycemia and inflammation on connexin43 expression in vitro in a mouse model of DR and in hu...
Autores principales: | Mugisho, Odunayo O., Green, Colin R., Zhang, Jie, Binz, Nicolette, Acosta, Monica L., Rakoczy, Elizabeth, Rupenthal, Ilva D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751170/ https://www.ncbi.nlm.nih.gov/pubmed/29186067 http://dx.doi.org/10.3390/ijms18122567 |
Ejemplares similares
-
Orally Delivered Connexin43 Hemichannel Blocker, Tonabersat, Inhibits Vascular Breakdown and Inflammasome Activation in a Mouse Model of Diabetic Retinopathy
por: Mugisho, Odunayo O., et al.
Publicado: (2023) -
Tonabersat Inhibits Connexin43 Hemichannel Opening and Inflammasome Activation in an In Vitro Retinal Epithelial Cell Model of Diabetic Retinopathy
por: Lyon, Heather, et al.
Publicado: (2020) -
Connexin therapeutics: blocking connexin hemichannel pores is distinct from blocking pannexin channels or gap junctions
por: Acosta, Monica L., et al.
Publicado: (2020) -
Xentry-Gap19 inhibits Connexin43 hemichannel opening especially during hypoxic injury
por: Coutinho, Frazer P., et al.
Publicado: (2020) -
Correlation between the progression of diabetic retinopathy and inflammasome biomarkers in vitreous and serum – a systematic review
por: Kuo, Charisse Y. J., et al.
Publicado: (2022)